Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01683526 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of Endotracheal Intubation Using Glidescope Video-Laryngoscope

A NA study of Respiratory Failure, sponsored by Beth Israel Medical Center.

Completed
Registry status
NA
Development phase
117
Enrollment target
1
Study location

NCT01683526: Completed NA study of Respiratory Failure, sponsored by Beth Israel Medical Center.

NCT01683526 is a NA study of Respiratory Failure that has completed, run by Beth Israel Medical Center. The registered enrollment target is 117 participants, below the 4,521-participant average among 40 other Respiratory Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01683526, a NA study of Respiratory Failure, has completed, sponsored by Beth Israel Medical Center.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target
1
Study location

Study Summary

The safety and efficacy of a video-laryngoscope as a primary intubation tool in urgent endotracheal intubation of critically-ill patients has not been well-described in the literature. This study will answer whether using a VL will impact on the efficacy and safety of intubation compared with a traditional direct laryngoscopy.

Conditions Studied

Interventions

  • PROCEDURE Direct laryngoscopy
  • DEVICE Video laryngoscopy (Glidescope)

Study Locations (1)

New York

  • Beth Isreal Medical Center - New York

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2012-08
Est. Completion 2013-04
Phase NA
Beth Israel Medical Center

44 total trials

What the finished NCT01683526 record still lists

NCT01683526 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 4,521-participant average among 40 other Respiratory Failure trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Direct laryngoscopy is the first listed.

NCT01683526 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01683526 about?

NCT01683526 is a clinical study titled "Safety and Efficacy of Endotracheal Intubation Using Glidescope Video-Laryngoscope". The safety and efficacy of a video-laryngoscope as a primary intubation tool in urgent endotracheal intubation of critically-ill patients has not been well-described in the literature. This study will answer whether using a VL will impact on the efficacy and safety of intubation compared with a trad...

What is the current status of trial NCT01683526?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2012-08. Estimated completion is 2013-04.

What conditions does trial NCT01683526 study?

This clinical trial studies the following conditions: Respiratory Failure.

What interventions are being tested in trial NCT01683526?

The interventions under investigation include: Direct laryngoscopy (PROCEDURE), Video laryngoscopy (Glidescope) (DEVICE).

Who is sponsoring clinical trial NCT01683526?

This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01683526 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01683526's enrollment target sits among peer trials

117 23rd of 40 higher than 18 of 40 other Respiratory Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03539822 · 117 participants · Phase 1

    Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

  • NCT03786692 · 117 participants · Phase 2

    Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

  • NCT04479696 · 117 participants · NA

    Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

  • NCT04940585 · 117 participants · NA

    ROSE in Sunset Park

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01683526, the US trial registry maintained by the National Library of Medicine. NCT01683526 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.